Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Evaluation of the EBMT risk score and of a modified EBMT risk score adapted to paediatric patients in paediatric allogeneic transplantation

Retrospective Studies

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Fanette Bernard

Outcome after allogeneic SCT for MLL-PTD AML

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type of treatment

Principal investigator

Marta Pratcorona

Prevalence and outcome of central nervous system (CNS) relapse after allogeneic stem cell transplantation (HSCT) in patients suffering from acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL)

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Lymphatic Leukaemia (ALL)

Acute Leukemia Working Party (ALWP)

Type of treatment

Principal investigator

Sabine BLUM , Yves Chalandon

HSCT experience in patients with Interferon gamma receptor deficiencies

Retrospective Studies

Inborn Errors Working Party (IEWP)

Type of treatment

Principal investigator

Outcomes of patients treated with Ibrutinib post autologous stem cell transplant for mantle cell lymphoma.

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Steve Robinson / Claire Burney

Autologous Stem Cell Transplantation International Crohn's Disease Trial: a multicentre, prospective, randomised phase II study conducted by the European Crohn's and Colitis Organisation (ECCO), sponsored by the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation

Clinical Trials Phase I-III

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Christopher J Hawkey

High dose immunoablation and autologous hematopoietic stem cell transplantation versus monthly intravenous pulse therapy cyclophosphamide in severe systemic sclerosis

Clinical Trials Phase I-III

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Autologous Stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study across Europe

Non-interventional Prospective Studies

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

Incidence and outcome of pregnancy following stem cell transplantation

Retrospective Studies

Complications: non-infectious

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

ASTIMS: High dose immunoablation and autologous haematopoietic stem cell transplantation versus mitoxantrone therapy in severe multiple sclerosis

Clinical Trials Phase I-III

Auto immune disorders

Autoimmune Diseases Working Party (ADWP)

Type of treatment

Principal investigator

LYM1: Rituximab Purging and/or Maintenance in Patients Undergoing Autologous Transplantation for Relapsed Follicular Lymphoma: A Prospective Randomized Trial From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Clinical Trials Phase I-III

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Ruth Pettengell

A Phase III Randomized, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of MK-8228 (Letermovir) for the Prevention of Clinically Significant Human Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients

Clinical Trials Phase I-III

Complications: infectious

Infectious Diseases Working Party (IDWP)

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator